Press Releases & Statements

November 15, 2011

First Combination ARV Vaginal Ring for HIV Prevention in Phase I Safety Trial

Paired with dapivirine, maraviroc makes debut as first entry inhibitor ARV to enter clinical trials as a vaginal microbicide PITTSBURGH, Nov. 15, 2011 –  In the first clinical trial of a vaginal ring... More »

July 13, 2011

Two Pivotal Studies Show Oral Antiretroviral Drugs Substantially Reduce Risk of HIV Infection in Men and Women

Confirms the power of ARVs to prevent HIV transmissionStatement from Dr. Zeda Rosenberg, CEO, International Partnership for MicrobicidesSILVER SPRING, Md. (July 13, 2011) — In a major step forward in... More »

April 18, 2011

Key Study to Assess Effectiveness of PrEP to Prevent HIV in Women Stopping Early Due to Futility

Inconclusive Results Underscore Urgency of Ongoing and Additional Research Statement from Dr. Zeda Rosenberg, CEO, International Partnership for Microbicides SILVER SPRING, Md. (April 18, 2011) –... More »

March 08, 2011

International Women’s Day: HIV Prevention Tools for Women Ever Closer

Statement from Dr. Zeda Rosenberg, CEO, International Partnership for Microbicides SILVER SPRING, Md. (March 8, 2011) — Since the first International Women’s Day was celebrated 100 years ago, women... More »

January 21, 2011

IPM Announces New Board Chair, Board Members and Executive Vice President for Product Development

Incoming Chair Peter B. Corr and Board members Georgina Caswell and Florence Manguyu offer expertise in pharmaceutical discovery and development, pediatrics and HIV prevention advocacy; Executive... More »

Pages